![Virtual Booth](https://www.pharmacompass.com/image/vb/vb-orange-btn.png)
![EuroAPI Header](https://www.pharmacompass.com/image/flap/euroapi-w34-desktop-headergif-72716.gif)
![EuroAPI Header](https://www.pharmacompass.com/image/flap/euroapi-w34-mob-headergif-95876.gif)
01 Malladi Drugs & Pharmaceuticals Limited (1)
02 Aarti Pharmalabs (1)
03 Sigmak Lifesciences (1)
04 Porton Pharma Solutions (1)
05 Anupam Rasayan India Ltd. (1)
06 Anvitha Lifecare (4)
07 Cangzhou Enke Pharma-tech Co., Ltd (1)
08 Enzymaster (Ningbo) Bio-Engineering (1)
09 Guangzhou Topwork Chemical (1)
10 Hangzhou Longshine Bio-Tech Co.,LTD (3)
11 Nanjing Lift Pharmaceutical Technology Co., Ltd (1)
12 Ningbo Zhenlei Chemical Co.,Ltd (3)
13 Shanghai Fine Pharma (7)
14 Tianjin Hankang Pharmaceutical Biotechnology (1)
01 162012-67-1 (4)
02 162012-69-3 (3)
03 314771-76-1 (2)
04 314771-88-5 (2)
05 367-21-5 (1)
06 53449-14-2 (1)
07 848133-35-7 (2)
08 86087-23-2 (7)
09 86087-24-3 (3)
10 86728-85-0 (1)
11 90866-33-4 (1)
01 China (19)
02 India (8)
Note: None of the products will be supplied to countries in which this could be in conflict with existing patents. Further, any products under patent will be offered for R&D purposes only. However, the final responsibility lies with the buyer.